Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG).

M Hallek; Martin Wilhelm; B Emmerich; H Dohner; HP Fostitsch; O Sezer; M Herold; W Knauf; R Busch; B Schmitt; CM Wendtner; R Kuse; M Freund; A Franke; F Schriever; C Nerl; E Thiel; W Hiddemann; G Brittinger

Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG).

M Hallek, Martin Wilhelm, B Emmerich, H Dohner, HP Fostitsch, O Sezer, M Herold, W Knauf, R Busch, B Schmitt, CM Wendtner, R Kuse, M Freund, A Franke, F Schriever, C Nerl, E Thiel, W Hiddemann, G Brittinger

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Abstract (Journal) › peer-review

5 Citations (Web of Science)

Original language	English
Pages (from-to)	313A-313A
Journal	BLOOD
Volume	94
Issue number	10
Publication status	Published - 1999

Cite this

Hallek, M., Wilhelm, M., Emmerich, B., Dohner, H., Fostitsch, HP., Sezer, O., Herold, M., Knauf, W., Busch, R., Schmitt, B., Wendtner, CM., Kuse, R., Freund, M., Franke, A., Schriever, F., Nerl, C., Thiel, E., Hiddemann, W., & Brittinger, G. (1999). Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG). BLOOD , 94(10), 313A-313A.

Hallek, M ; Wilhelm, Martin ; Emmerich, B et al. / Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG). In: BLOOD 1999 ; Vol. 94, No. 10. pp. 313A-313A.

@article{55940652acd54ad8b97aae3b8ea0fb2f,

title = "Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG).",

author = "M Hallek and Martin Wilhelm and B Emmerich and H Dohner and HP Fostitsch and O Sezer and M Herold and W Knauf and R Busch and B Schmitt and CM Wendtner and R Kuse and M Freund and A Franke and F Schriever and C Nerl and E Thiel and W Hiddemann and G Brittinger",

year = "1999",

language = "English",

volume = "94",

pages = "313A--313A",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "10",

}

Hallek, M, Wilhelm, M, Emmerich, B, Dohner, H, Fostitsch, HP, Sezer, O, Herold, M, Knauf, W, Busch, R, Schmitt, B, Wendtner, CM, Kuse, R, Freund, M, Franke, A, Schriever, F, Nerl, C, Thiel, E, Hiddemann, W & Brittinger, G 1999, 'Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG).', BLOOD , vol. 94, no. 10, pp. 313A-313A.

Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG). / Hallek, M; Wilhelm, Martin; Emmerich, B et al.
In: BLOOD , Vol. 94, No. 10, 1999, p. 313A-313A.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG).

AU - Hallek, M

AU - Wilhelm, Martin

AU - Emmerich, B

AU - Dohner, H

AU - Fostitsch, HP

AU - Sezer, O

AU - Herold, M

AU - Knauf, W

AU - Busch, R

AU - Schmitt, B

AU - Wendtner, CM

AU - Kuse, R

AU - Freund, M

AU - Franke, A

AU - Schriever, F

AU - Nerl, C

AU - Thiel, E

AU - Hiddemann, W

AU - Brittinger, G

PY - 1999

Y1 - 1999

M3 - Abstract (Journal)

SN - 0006-4971

VL - 94

SP - 313A-313A

JO - BLOOD

JF - BLOOD

IS - 10

ER -

Hallek M, Wilhelm M, Emmerich B, Dohner H, Fostitsch HP, Sezer O et al. Fludarabine plus cyclophosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two phase II studies (CLL2-protocol) of the german cll study group (GCLLSG). BLOOD . 1999;94(10):313A-313A.